「news2022年12月28日添付文書」の検索結果
168件：101～105件目を表示
-
Medical devices and healthcare | Business Activities | About Senju | SENJU Pharmaceutical
We will contribute to medical care and your health requirements in the new era through medical devices. Today, in the era of the 100-year-life, digital transformation is being promoted in various fiel
https://www.senju.co.jp/english/about/business/device.html -
Mytear EYETECT ALPITATTO | OTC Products, etc. | Products | SENJU Pharmaceutical
This medicine is recommended for people who have continuing allergy symptoms with inflammation. Category 2 OTC medicines Mytear® EYETECT® ALPITATTO Works on unpleasant eye itching due to pollens and o
https://www.senju.co.jp/english/products/ap.html -
研究開発の取り組み | 千寿製薬株式会社
R & D activities Product Development Policy Research and Development System R & D Pipeline Clinical trial information Publications Meetings of the Minds Business Collaboration Inquiries licens
https://www.senju.co.jp/english/rd/ -
MytearV | OTC Products, etc. | Products | SENJU Pharmaceutical
Category 2 OTC medicines Mytear® V Resolves redness of the eye and provides healthy and clear eyes. CHARACTERISTICS Compounded with "tetrahydrozoline hydrochloride", a component to relieve r
https://www.senju.co.jp/english/products/mytearv.html -
Over-The-Counter Medicines | Business Activities | About Senju | SENJU Pharmaceutical
From eye drops to contact lens preparations-Mytear eye solutions head a diverse line of trusted products Building on a reputation for excellence in ophthalmological drugs, Senju Pharmaceutical has cul
https://www.senju.co.jp/english/about/business/otc.html